• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inmune Bio Inc (NQ: INMB )

    6.130 -0.090 (-1.45%)
    Streaming Delayed Price Updated: 11:58 AM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Inmune Bio Inc

    < Previous 1 2 3 4 5 Next >
    28 Stocks Moving in Thursday's Pre-Market Session
    Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers INmune Bio (NASDAQ:INMB) shares ... 
    Via Benzinga
    Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon?
    INmune Bio, Inc. (NASDAQ: INMB) shares traded higher Wednesday afternoon following data out of a trial for the company's Alzheimer's drug candidate. The company said its... 
    Via Benzinga
    10 Stocks Moving In Wednesday's After-Hours Session
    Gainers INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging... 
    Via Benzinga
    Analyzing INmune Bio's Unusual Options Activity
    On Wednesday, shares of INmune Bio (NASDAQ:INMB) saw unus... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
    Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and... 
    Via Talk Markets
    The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
    Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... 
    Via Benzinga
    INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial
    INmune Bio Inc (NASDAQ: INMB) announced that the first patient who received INKmune has successfully shown NK activation and functional differentiation. INKmune is... 
    Via Benzinga
    The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures COVID-19
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The company's market cap stands at $8.1 billion.... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Cocrystal Pharma (NASDAQ:COCP) stock moved upwards by 30.9% to $1.44 during Thursday's pre-market session. The company's market cap stands at $140.3... 
    Via Benzinga
    Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
    Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
    Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
    Via Benzinga
    Exposures Product Safety
    74 Biggest Movers From Yesterday
    Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with... 
    Via Benzinga
    INmune Bio Issues Equity Raise Of $40M At 18% Discount To Fund Alzheimer's Candidate Development
    INmune Bio Inc (NASDAQ: INMB) has announced a direct offering of 1.8 million shares at $22.00 per share for gross proceeds of approximately $40 million. The... 
    Via Benzinga
    55 Biggest Movers From Yesterday
    Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
    Via Benzinga
    64 Biggest Movers From Friday
    Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock... 
    Via Benzinga
    40 Stocks Moving In Friday's Mid-Day Session
    Gainers Stamps.com Inc. (NASDAQ: STMP) jumped 63.7% to $323.63. Software investment firm Thoma Bravo inked an agreement to acquire e-commerce shipping solutions provider Stamps.... 
    Via Benzinga
    Biotechs Ready To Roar
    The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector... 
    Via Talk Markets
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers Atossa Therapeutics (NASDAQ:ATOS)... 
    Via Benzinga
    61 Biggest Movers From Yesterday
    Gainers Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday. Mannatech, Incorporated (NASDAQ: MTEX)... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... 
    Via Benzinga
    60 Biggest Movers From Yesterday
    Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
    Via Benzinga
    INmune Bio, Inc. (INMB) Q1 2021 Earnings Call Transcript
    INMB earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    48 Biggest Movers From Yesterday
    Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
    Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.